Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: A Comparative Study To Evaluate The Efficacy Of Intralesional Measles, Mumps And Rubella Vaccine And Intralesional Vitamin D3 In The Treatment Of Extragenital Warts: Our study is a rand
Sponsors
Dr Trisha Patel
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinically confirmed cases of all type of warts in age groups >2 years and <70 years included in the study.
Exclusion criteria
Exclusion criteria: 1) Immunocompromised patient such as patient taking anticancer drug, immunosuppressive drugs, steroids. 2) Patients with clinical history of immunosuppression. 3) Pregnant female (Married females in reproductive age group are excluded by UPT) and Lactating females, patient with generalized eczema, infective dermatosis, and patient with known hypersensitivity to Vit-D3 or MMR immunotherapy 4) Any acute illness/ acute febrile illness 5) Children less than 2 years 6) Patients with inflamed warts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Partial or complete resolution of the viral warts in majority of the casesTimepoint: The patient will be evaluated at the beginning of study and then at interval of 21 days for 4 time. After that patient will be followed up at the interval of 3 and 6 months to see for recurrence. | — |
Secondary
| Measure | Time frame |
|---|---|
| We will be able to evaluate the process of regression of the viral wartTimepoint: we will have an evaluation of disease activity at every 21 days and see for recurrence at the end of 6 months after the last injection | — |
Countries
India
Contacts
Public ContactDr Trisha Patel
PRAMUKH SWAMI MEDICAL COLLEGE AND SHREE KRISHNA HOSPITAL
Outcome results
None listed